Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TARO TO INTRODUCE ONE DOZEN "NICHE" OTCs BY END OF 1994

This article was originally published in The Tan Sheet

Executive Summary

TARO TO INTRODUCE ONE DOZEN "NICHE" OTCs BY END OF 1994 in the U.S. and Canada that will be imported from the firm's manufacturing facilities in Israel, Taro Senior VP and Chief Operating Officer Peter Giallorenzo told analysts at the recent Kidder, Peabody Healthcare Conference in New York City. Taro said the majority of the OTCs will be marketed in the cough/cold and analgesic categories in both topical and liquid forms. To date, the company's primary focus has been on products in the dermatologic category.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082714

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel